Original papers

Efficacy and safety of biosimilar IFX (CT-P13) and adalimumab in patients with active fistulizing perianal Crohn’s disease naïve to anti-TNF therapy: preliminary results from the POLIBD study

Anna Pękala
David Aebisher
Piotr Pardak
Rafal Filip

Review papers

Case reports